Hepatobiliary and pancreatic disorders for which hepatectomy, pancreaticoduodenectomy or distal pancreatectomy are indicated
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 and above who undergo hepatectomy, pancreaticoduodenectomy, and pancreatectomy between the trial start date and December 31, 2025 at the Department of Hepato-Biliary-Pancreatic and Transplant Surgery at the University of Tokyo Hospital, as well as the surgery department at affiliated hospital.
Exclusion criteria
Exclusion criteria: Patients aged 17 and below. Patients who do not consent to participation in this study. Patients undergoing hepatopancreatoduodenectomy. Patients undergoing hepatectomy with extrahepatic bile duct resection.Patients requiring reoperation due to postoperative complications. Distal pancreatectomy with combined resection of the celiac artery trunk. Cases deemed difficult to resect intraoperatively. Cases involving combined resection of other organs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The EQ-5D index value of the patients receiving hepatectomy, pancreaticoduodenectomy and distal pancreatectomy on postoperative day 5, 21-28, 50-70 | — |
Secondary
| Measure | Time frame |
|---|---|
| The distribution of responses to each question on the EQ-5D-5L questionnaire for patients receiving hepatectomy, pancreaticoduodenectomy and distal pancreatectomy on postoperative day 5, 21-28, 50-70, patient physical activity using an activity tracker | — |
Countries
Japan
Contacts
The university of Tokyo hospital Hepato-biliary-Pancreatic Surgery Division and Artificial Organ and Transplantation Division